Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Research Project (R01)
Project #
1R01NS027757-01A1
Application #
3414161
Study Section
Pathology A Study Section (PTHA)
Project Start
1990-04-01
Project End
1993-03-31
Budget Start
1990-04-01
Budget End
1991-03-31
Support Year
1
Fiscal Year
1990
Total Cost
Indirect Cost
Name
Oregon Health and Science University
Department
Type
Schools of Medicine
DUNS #
009584210
City
Portland
State
OR
Country
United States
Zip Code
97239
Remsen, L G; McCormick, C I; Roman-Goldstein, S et al. (1996) MR of carcinoma-specific monoclonal antibody conjugated to monocrystalline iron oxide nanoparticles: the potential for noninvasive diagnosis. AJNR Am J Neuroradiol 17:411-8
Kroll, R A; Pagel, M A; Muldoon, L L et al. (1996) Increasing volume of distribution to the brain with interstitial infusion: dose, rather than convection, might be the most important factor. Neurosurgery 38:746-52;discussion 752-4
Kroll, R A; Pagel, M A; Roman-Goldstein, S et al. (1995) White matter changes associated with feline GM2 gangliosidosis (Sandhoff disease): correlation of MR findings with pathologic and ultrastructural abnormalities. AJNR Am J Neuroradiol 16:1219-26
Kroll, R A; Pagel, M A; Langone, J J et al. (1994) Differential permeability of the blood-tumour barrier in intracerebral tumour-bearing rats: antidrug antibody to achieve systemic drug rescue. Ther Immunol 1:333-41
Muldoon, L L; Neuwelt, E A; Pagel, M A et al. (1994) Characterization of the molecular defect in a feline model for type II GM2-gangliosidosis (Sandhoff disease). Am J Pathol 144:1109-18
Neuwelt, E A; Weissleder, R; Nilaver, G et al. (1994) Delivery of virus-sized iron oxide particles to rodent CNS neurons. Neurosurgery 34:777-84
Neuwelt, E A; Pagel, M A; Dix, R D (1991) Delivery of ultraviolet-inactivated 35S-herpesvirus across an osmotically modified blood-brain barrier. J Neurosurg 74:475-9
Roman-Goldstein, S M; Barnett, P A; McCormick, C I et al. (1991) Effects of gadopentetate dimeglumine administration after osmotic blood-brain barrier disruption: toxicity and MR imaging findings. AJNR Am J Neuroradiol 12:885-90